TGFB1 and glioma: The strategies directed to the ECM stiffness in glioma include drugs targeting TGF-β, recognized as key factor in collagen synthesis, collagenases to directly degrade collagen, and inhibition of collagen cross-linking (reviewed in Huang et al. 2021).